6a,11a-Dihydro-6-methoxy-8,9-(methylenedioxy)-6H-benzofuro[3,2-c][1]benzopyran-3-ol - Names and Identifiers
Name | Sophoracarpan B
|
Synonyms | Sophoracarpan B 6a,11a-Dihydro-6-methoxy-8,9-(methylenedioxy)-6H-benzofuro[3,2-c][1]benzopyran-3-ol 6H-[1,3]Dioxolo[5,6]benzofuro[3,2-c][1]benzopyran-3-ol, 6a,12a-dihydro-6-methoxy-, (6S,6aS,12aR)-
|
CAS | 1674359-84-2
|
6a,11a-Dihydro-6-methoxy-8,9-(methylenedioxy)-6H-benzofuro[3,2-c][1]benzopyran-3-ol - Physico-chemical Properties
Molecular Formula | C17H14O6
|
Molar Mass | 314.29 |
Appearance | Powder |
Storage Condition | 2-8℃ |
6a,11a-Dihydro-6-methoxy-8,9-(methylenedioxy)-6H-benzofuro[3,2-c][1]benzopyran-3-ol - Introduction
Sophoracarpan B is a natural product, mainly found in Neem (Sophora flavescens) and Chinese vetch (Lobelia chinensis). The following is a description of the nature, use, formulation and safety information of Sophoracarpan B:
Properties: Sophoracarpan B is a yellow crystal with a bitter taste. Its molecular formula is C22H18O6 and its molecular weight is 378.38.
Uses: Sophoracarpan B has a variety of biological activities, it is widely used as a plant antibacterial agent, antioxidant and anti-inflammatory agent. In addition, it is also being investigated as a potential candidate for anticancer drugs.
preparation method: most of the preparation methods of Sophoracarpan B are extracted from neem or milk vetch. First, the plant material can be extracted using a solvent (e. G., alcohol, ether, etc.) and then purified by distillation, crystallization, and purification.
Safety information: At present, there are few safety studies on Sophoracarpan B, so its toxicity and side effects are not clear. When using, it is recommended to follow the laboratory's safe operating practices and pay close attention to the risks of exposure, inhalation and ingestion to avoid possible hazards. In addition, any drug or chemical substance applied to the human body should be used with caution and under professional guidance. If necessary, please consult relevant professionals or pharmaceutical experts for specific evaluation and guidance.
Last Update:2024-04-09 21:01:54